ALNY Insider Trading

Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $8,656,347.04

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $149.40
Price Change: Price Decrease of -1.82 (-1.20%)
As of 05/17/2024 01:00 AM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890View SEC Filing Icon  
4/27/2023Jeffrey V. PoultonCFOSell977$194.59$190,114.4311,706View SEC Filing Icon  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800View SEC Filing Icon  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801View SEC Filing Icon  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332View SEC Filing Icon  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00View SEC Filing Icon  
3/3/2023Pushkal GargCMOSell18,072$200.00$3,614,400.004,345View SEC Filing Icon  
2/2/2023Indrani Lall FranchiniEVPSell1,675$226.01$378,566.753,500View SEC Filing Icon  
8/5/2022Tolga TangulerEVPSell1,841$218.16$401,632.56View SEC Filing Icon  
8/3/2022Tolga TangulerEVPSell1,754$210.00$368,340.003,629View SEC Filing Icon  
7/5/2022Tolga TangulerEVPSell1,754$150.00$263,100.001,754View SEC Filing Icon  
4/1/2022Steven M. PaulDirectorSell15,000$170.69$2,560,350.001,000View SEC Filing Icon  
12/23/2021Akshay VaishnawInsiderSell2,879$190.93$549,687.47View SEC Filing Icon  
11/12/2021John MaraganoreCEOSell33,978$171.52$5,827,906.56View SEC Filing Icon  
8/13/2021John MaraganoreCEOSell33,979$199.78$6,788,324.62248,744View SEC Filing Icon  
8/6/2021Yvonne GreenstreetCOOSell53,064$199.00$10,559,736.00View SEC Filing Icon  
8/5/2021Laurie KeatingEVPSell10,000$188.95$1,889,500.0013,008View SEC Filing Icon  
7/12/2021Laurie KeatingEVPSell6,812$178.96$1,219,075.526,944View SEC Filing Icon  
6/18/2021Akshay VaishnawInsiderSell14,708$175.00$2,573,900.0024,953View SEC Filing Icon  
6/9/2021Laurie KeatingEVPSell1,734$154.00$267,036.005,132View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/17/2024Plato Investment Management Ltd4,509$0.67M0.1%+2,666.3%0.004%Search for SEC Filing on Google Icon
5/17/2024iA Global Asset Management Inc.7,765$1.16M0.0%+28.2%0.006%Search for SEC Filing on Google Icon
5/17/2024Comerica Bank13,003$1.94M0.0%-2.7%0.010%Search for SEC Filing on Google Icon
5/17/2024Tidal Investments LLC10,281$1.54M0.0%+292.3%0.008%Search for SEC Filing on Google Icon
5/17/2024Motley Fool Asset Management LLC1,960$0.29M0.0%-3.7%0.002%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System191,418$28.61M0.0%-0.1%0.151%Search for SEC Filing on Google Icon
5/16/2024Jacobs Levy Equity Management Inc.126,367$18.89M0.1%N/A0.100%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC178,954$26.74M0.0%-35.6%0.141%Search for SEC Filing on Google Icon
5/16/2024Kennedy Capital Management LLC1,548$0.23M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/16/2024Paloma Partners Management Co3,250$0.49M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/15/2024Public Employees Retirement System of Ohio51,548$7.70M0.0%-7.0%0.041%Search for SEC Filing on Google Icon
5/15/2024Public Employees Retirement Association of Colorado13,875$2.07M0.0%-3.6%0.011%Search for SEC Filing on Google Icon
5/15/2024Bellevue Group AG918,284$137.24M2.1%+3.7%0.726%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD3,685,753$550.84M0.1%+5.8%2.914%Search for SEC Filing on Google Icon
5/15/2024BOKF NA6,712$1.03M0.0%+23.9%0.005%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC300,000$44.84M0.5%-73.0%0.237%Search for SEC Filing on Google Icon
5/15/2024Altitude Crest Partners Inc.200$30K0.0%N/A0.000%Search for SEC Filing on Google Icon
5/14/2024Canada Pension Plan Investment Board273,790$40.92M0.0%+12.7%0.216%Search for SEC Filing on Google Icon
5/14/2024Capital World Investors12,789,236$1.91B0.3%-20.9%10.111%Search for SEC Filing on Google Icon
5/14/2024Capital Research Global Investors3,144,987$470.02M0.1%+7.3%2.486%Search for SEC Filing on Google Icon
5/14/2024Capital International Sarl73,109$10.93M0.4%-16.3%0.058%Search for SEC Filing on Google Icon
5/14/2024Toronto Dominion Bank12,986$1.94M0.0%-73.6%0.010%Search for SEC Filing on Google Icon
5/14/2024Capital International Ltd. CA65,224$9.75M0.5%-26.2%0.052%Search for SEC Filing on Google Icon
5/14/2024Capital International Inc. CA 93,376$13.96M0.2%-6.6%0.074%Search for SEC Filing on Google Icon
5/14/2024Capital International Investors3,651,217$545.67M0.1%+1.8%2.887%Search for SEC Filing on Google Icon
5/14/2024Capital Group Private Client Services Inc.54,421$8.13M0.1%+9.4%0.043%Search for SEC Filing on Google Icon
5/14/2024Capital Group Investment Management PTE. LTD.16,173$2.42M0.4%-50.1%0.013%Search for SEC Filing on Google Icon
5/14/2024Advisors Asset Management Inc.4,037$0.60M0.0%+194.0%0.003%Search for SEC Filing on Google Icon
5/14/2024EntryPoint Capital LLC1,724$0.26M0.2%+70.2%0.001%Search for SEC Filing on Google Icon
5/14/2024Shell Asset Management Co.2,180$0.33M0.0%-42.6%0.002%Search for SEC Filing on Google Icon
5/14/2024Natixis682$0.10M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/14/2024CANADA LIFE ASSURANCE Co47,545$7.11M0.0%+3.9%0.038%Search for SEC Filing on Google Icon
5/14/2024National Bank of Canada FI108,410$16.31M0.0%+21,032.6%0.086%Search for SEC Filing on Google Icon
5/13/2024UniSuper Management Pty Ltd1,800$0.27M0.0%+100.0%0.001%Search for SEC Filing on Google Icon
5/13/2024Seven Eight Capital LP25,809$3.86M0.4%+392.8%0.020%Search for SEC Filing on Google Icon
5/13/2024O Shaughnessy Asset Management LLC2,181$0.33M0.0%+9.6%0.002%Search for SEC Filing on Google Icon
5/11/2024Covestor Ltd732$0.11M0.1%+105.0%0.001%Search for SEC Filing on Google Icon
5/11/2024Edgestream Partners L.P.23,355$3.49M0.2%+193.4%0.018%Search for SEC Filing on Google Icon
5/10/2024Ontario Teachers Pension Plan Board1,833$0.27M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/10/2024Acadian Asset Management LLC1,659$0.25M0.0%+30.3%0.001%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.11,994,261$1.79B0.0%+0.4%9.482%Search for SEC Filing on Google Icon
5/10/2024Intech Investment Management LLC10,885$1.63M0.0%+44.3%0.009%Search for SEC Filing on Google Icon
5/10/2024Mitsubishi UFJ Trust & Banking Corp311,852$46.61M0.1%-10.7%0.247%Search for SEC Filing on Google Icon
5/9/2024Beacon Investment Advisory Services Inc.5,018$0.75M0.0%-8.0%0.004%Search for SEC Filing on Google Icon
5/9/2024Mitsubishi UFJ Asset Management Co. Ltd.68,790$10.28M0.0%+22.5%0.054%Search for SEC Filing on Google Icon
5/9/2024Souders Financial Advisors3,476$0.52M0.1%+18.0%0.003%Search for SEC Filing on Google Icon
5/9/2024State Board of Administration of Florida Retirement System137,022$20.48M0.0%+0.8%0.108%Search for SEC Filing on Google Icon
5/9/2024TD Asset Management Inc462,348$69.10M0.1%-0.8%0.366%Search for SEC Filing on Google Icon
5/8/2024Motley Fool Asset Management LLC1,960$0.29M0.0%-3.7%0.002%Search for SEC Filing on Google Icon
5/8/2024Bleakley Financial Group LLC1,938$0.29M0.0%-4.3%0.002%Search for SEC Filing on Google Icon
5/8/2024ProShare Advisors LLC8,827$1.32M0.0%+10.1%0.007%Search for SEC Filing on Google Icon
5/8/2024US Bancorp DE6,560$0.98M0.0%-9.5%0.005%Search for SEC Filing on Google Icon
5/8/2024Headlands Technologies LLC3,150$0.47M0.1%N/A0.002%Search for SEC Filing on Google Icon
5/7/2024Susquehanna Fundamental Investments LLC88,067$13.16M0.6%N/A0.070%Search for SEC Filing on Google Icon
5/7/2024Swiss National Bank375,900$56.18M0.0%-3.8%0.297%Search for SEC Filing on Google Icon
5/7/2024Forsta AP Fonden68,300$10.21M0.1%+199.6%0.054%Search for SEC Filing on Google Icon
5/7/2024Illinois Municipal Retirement Fund26,375$3.94M0.1%N/A0.021%Search for SEC Filing on Google Icon
5/7/2024Oppenheimer & Co. Inc.1,716$0.26M0.0%-60.8%0.001%Search for SEC Filing on Google Icon
5/7/2024ANTIPODES PARTNERS Ltd205,579$30.72M1.0%+8.7%0.163%Search for SEC Filing on Google Icon
5/7/2024Empowered Funds LLC13,849$2.07M0.0%+3.9%0.011%Search for SEC Filing on Google Icon
5/6/2024Duality Advisers LP11,197$1.67M0.2%-34.6%0.009%Search for SEC Filing on Google Icon
5/3/2024Mediolanum International Funds Ltd38,556$5.95M0.1%N/A0.031%Search for SEC Filing on Google Icon
5/3/2024Central Pacific Bank Trust Division1,050$0.16M0.0%N/A0.001%Search for SEC Filing on Google Icon
5/2/2024Daiwa Securities Group Inc.10,921$1.63M0.0%+1.1%0.009%Search for SEC Filing on Google Icon
5/2/2024Nordea Investment Management AB8,980$1.37M0.0%+3.3%0.007%Search for SEC Filing on Google Icon
5/2/2024Tobam69,062$10.32M0.9%-24.1%0.055%Search for SEC Filing on Google Icon
5/2/2024Tokio Marine Asset Management Co. Ltd.3,849$0.58M0.0%+7.7%0.003%Search for SEC Filing on Google Icon
5/2/2024Moloney Securities Asset Management LLC2,389$0.36M0.1%N/A0.002%Search for SEC Filing on Google Icon
5/1/2024Janney Montgomery Scott LLC2,775$0.42M0.0%+47.4%0.002%Search for SEC Filing on Google Icon
5/1/2024Mirae Asset Global Investments Co. Ltd.62,415$9.33M0.0%+63.4%0.050%Search for SEC Filing on Google Icon
5/1/2024Baillie Gifford & Co.6,623,577$989.89M0.8%-4.9%5.259%Search for SEC Filing on Google Icon
5/1/2024Sequoia Financial Advisors LLC2,910$0.44M0.0%-62.3%0.002%Search for SEC Filing on Google Icon
4/30/2024Van ECK Associates Corp57,923$8.66M0.0%-5.4%0.046%Search for SEC Filing on Google Icon
4/30/2024Privium Fund Management B.V.20,893$3.12M0.8%-3.7%0.017%Search for SEC Filing on Google Icon
4/30/2024Allspring Global Investments Holdings LLC168$25K0.0%+572.0%0.000%Search for SEC Filing on Google Icon
4/30/2024Commonwealth Equity Services LLC5,594$0.84M0.0%+32.3%0.004%Search for SEC Filing on Google Icon
4/29/2024Greenleaf Trust2,863$0.43M0.0%-2.6%0.002%Search for SEC Filing on Google Icon
4/29/2024Principal Financial Group Inc.19,356$2.89M0.0%-1.4%0.015%Search for SEC Filing on Google Icon
4/29/2024China Universal Asset Management Co. Ltd.35,822$5.35M0.7%+36.9%0.028%Search for SEC Filing on Google Icon
4/26/2024Prestige Wealth Management Group LLC472$71K0.0%+69.8%0.000%Search for SEC Filing on Google Icon
4/26/2024Yousif Capital Management LLC1,635$0.24M0.0%+9.7%0.001%Search for SEC Filing on Google Icon
4/25/2024Lindbrook Capital LLC236$35K0.0%-36.0%0.000%Search for SEC Filing on Google Icon
4/25/2024Zurcher Kantonalbank Zurich Cantonalbank 50,014$7.48M0.0%+10.9%0.040%Search for SEC Filing on Google Icon
4/25/2024Fjarde AP Fonden Fourth Swedish National Pension Fund27,415$4.10M0.0%-1.8%0.022%Search for SEC Filing on Google Icon
4/24/2024Simplicity Wealth LLC1,934$0.29M0.0%N/A0.002%Search for SEC Filing on Google Icon
4/24/2024Assenagon Asset Management S.A.60,342$9.02M0.0%+326.0%0.048%Search for SEC Filing on Google Icon
4/22/2024EFG Asset Management Americas Corp.10,886$1.63M0.5%-33.0%0.009%Search for SEC Filing on Google Icon
4/22/2024IFM Investors Pty Ltd25,651$3.83M0.0%+3.1%0.020%Search for SEC Filing on Google Icon
4/22/2024GraniteShares Advisors LLC3,177$0.48M0.3%+13.9%0.003%Search for SEC Filing on Google Icon
4/20/2024Maryland State Retirement & Pension System9,836$1.44M0.0%+4.1%0.008%Search for SEC Filing on Google Icon
4/19/2024First Trust Direct Indexing L.P.2,656$0.40M0.0%-8.4%0.002%Search for SEC Filing on Google Icon
4/19/2024Sumitomo Mitsui Trust Holdings Inc.290,996$43.49M0.0%-1.5%0.231%Search for SEC Filing on Google Icon
4/18/2024Quattro Financial Advisors LLC5,000$0.75M0.2%+2,517.8%0.004%Search for SEC Filing on Google Icon
4/18/2024Allspring Global Investments Holdings LLC168$25K0.0%+572.0%0.000%Search for SEC Filing on Google Icon
4/18/2024SteelPeak Wealth LLC6,860$1.03M0.1%+147.7%0.005%Search for SEC Filing on Google Icon
4/5/2024First Hawaiian Bank4,000$0.60M0.0%-96.4%0.003%Search for SEC Filing on Google Icon
4/5/2024Los Angeles Capital Management LLC2,959$0.44M0.0%-82.6%0.002%Search for SEC Filing on Google Icon
3/22/2024PNC Financial Services Group Inc.13,118$2.51M0.0%-16.3%0.010%Search for SEC Filing on Google Icon
3/11/2024Vanguard Group Inc.11,943,895$2.29B0.0%+2.5%9.483%Search for SEC Filing on Google Icon
3/1/2024Goldman Sachs Group Inc.291,368$55.77M0.0%-6.6%0.231%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $149.40
Low: $148.32
High: $151.84

50 Day Range

MA: $149.25
Low: $143.31
High: $156.04

52 Week Range

Now: $149.40
Low: $141.98
High: $218.88

Volume

481,247 shs

Average Volume

505,605 shs

Market Capitalization

$18.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.41

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Yvonne Greenstreet (CEO)
  2. Akshay Vaishnaw (President)
  3. Michael W Bonney (Director)
  4. Jeffrey V Poulton (CFO)
  5. Pushkal Garg (CMO)
  6. Tolga Tanguler (EVP)
  7. Indrani Lall Franchini (EVP)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Capital World Investors — 10.11%
  2. Vanguard Group Inc. — 9.48%
  3. Baillie Gifford & Co. — 5.26%
  4. Price T Rowe Associates Inc. MD — 2.91%
  5. Capital International Investors — 2.89%
  6. Capital Research Global Investors — 2.49%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. Capital World Investors
  2. Avoro Capital Advisors LLC
  3. Baillie Gifford & Co.
  4. First Hawaiian Bank
  5. Janus Henderson Group PLC
  6. Mitsubishi UFJ Trust & Banking Corp
  7. Toronto Dominion Bank
  8. Capital International Ltd. CA
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Akshay Vaishnaw (President)
  3. Michael W Bonney (Director)
  4. Jeffrey V Poulton (CFO)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Capital Research Global Investors
  2. Price T Rowe Associates Inc. MD
  3. Jacobs Levy Equity Management Inc.
  4. National Bank of Canada FI
  5. Jane Street Group LLC
  6. Susquehanna Fundamental Investments LLC
  7. Capital International Investors
  8. Vanguard Group Inc.